What is the likely cause and management of recurrent hematemesis (vomiting blood) in a 15-year-old boy with a history of similar episodes and esophageal injury on endoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis and Management of Recurrent Hematemesis in a 15-Year-Old with Esophageal Injury

In a 15-year-old boy with recurrent hematemesis and documented esophageal injury on endoscopy, the most likely diagnoses are severe erosive esophagitis from gastroesophageal reflux disease (GERD), pill-induced esophageal ulceration, or less commonly, esophageal varices from underlying liver disease—immediate repeat endoscopy with high-dose proton pump inhibitor (PPI) therapy is indicated to assess healing and guide definitive management. 1, 2, 3

Primary Differential Diagnoses

GERD-Related Esophageal Injury (Most Likely)

  • Severe erosive esophagitis is the most common cause of esophageal injury with recurrent bleeding in adolescents, accounting for 65.9% of esophageal ulcers in one large series 3
  • GERD-induced esophageal ulcers typically measure 2-3 cm in size and are located in the lower thoracic esophagus in 80.3% of cases 3
  • Bleeding from reflux esophagitis occurs in 8.2% of patients with GERD, with grade 3-4 esophagitis having an odds ratio of 25.5 for bleeding 4
  • Critical pitfall: A history of heartburn or reflux symptoms is present in only 28-37% of patients with bleeding esophagitis, so absence of typical GERD symptoms does not exclude this diagnosis 4

Drug-Induced Esophageal Ulceration (Second Most Common)

  • Pill esophagitis accounts for 22.7% of esophageal ulcers and should be strongly considered in adolescents who may take NSAIDs, antibiotics (especially doxycycline), or bisphosphonates 3
  • Drug-induced ulcers average 2.92 cm in size but are more commonly located in the mid-esophagus (86.2%) rather than the lower esophagus 3
  • Key distinguishing feature: Mid-esophageal ulcers have a greater tendency to hemorrhage compared to gastroesophageal junction ulcers 3

Esophageal Varices (Must Exclude)

  • While uncommon in adolescents without known liver disease, variceal bleeding carries 20% mortality at 6 weeks and must be ruled out 1
  • Endoscopy should specifically document presence or absence of varices, as management differs completely from non-variceal bleeding 1

Rare but Important Considerations

  • Acute necrotizing esophagitis: Presents with upper GI bleeding in elderly or critically ill patients, affects lower two-thirds of esophagus in 59% of cases 5
  • Infectious esophagitis: Candidal (3.4%), HSV, or HIV-related in immunocompromised patients 3
  • Mallory-Weiss tear: From forceful vomiting, but typically single episode rather than recurrent 1

Immediate Management Algorithm

Step 1: Stabilization and Risk Assessment

  • Hemodynamic stabilization is mandatory before endoscopy—restore intravascular volume and stabilize blood pressure 2
  • Maintain hemoglobin 7-9 g/dL with restrictive transfusion strategy if variceal bleeding suspected 1, 2
  • Place nasogastric tube to assess for active bleeding (prognostic value) 2

Step 2: Pharmacological Therapy (Start Immediately)

  • Initiate high-dose PPI therapy immediately: 80 mg omeprazole IV bolus followed by 8 mg/hour continuous infusion for 72 hours 2, 6
  • If variceal bleeding is suspected based on history or clinical presentation, start vasoactive agents (octreotide or terlipressin) immediately before endoscopy 1, 2
  • Administer erythromycin 250 mg IV 30-60 minutes before endoscopy to improve visualization 2

Step 3: Urgent Endoscopy

  • Perform endoscopy within 24 hours to identify bleeding source and provide therapeutic intervention 1, 2
  • Endoscopy must document: exact location of injury, size of ulcer/erosion, presence of active bleeding or stigmata of recent hemorrhage, and presence/absence of varices 1
  • Endoscopic therapy indications: Active bleeding (spurting or oozing), non-bleeding visible vessel, or adherent clot 1, 2

Step 4: Therapeutic Endoscopic Intervention

For non-variceal bleeding:

  • Combination therapy is superior: Mechanical therapy (hemoclips) plus injection therapy (1:10,000 epinephrine) is more effective than injection alone 1, 2
  • Inject 4-16 mL of epinephrine solution in quadrants around bleeding point 1
  • Apply hemoclips or thermal coagulation (heater probe 20-30 joules) for definitive hemostasis 1

For variceal bleeding (if present):

  • Endoscopic variceal ligation (EVL) is the treatment of choice 1
  • Continue vasoactive agents for 2-5 days 1
  • Initiate short-term antibiotic prophylaxis 1, 2

Follow-Up Management Based on Endoscopic Findings

If Severe Erosive Esophagitis (Grade B or Worse)

  • Continue high-dose PPI therapy: Transition to oral omeprazole 40 mg twice daily for 8 weeks 1, 6
  • Mandatory repeat endoscopy at 8 weeks to ensure healing and rule out Barrett's esophagus 1
  • If healing is incomplete, continue PPI therapy for additional 4 weeks 1
  • Long-term maintenance: Once healed, continue once-daily PPI indefinitely to prevent recurrence 1, 6

If Drug-Induced Esophageal Ulcer

  • Discontinue offending medication immediately 3
  • PPI therapy for 6-8 weeks to allow mucosal healing 2
  • Important: Drug-induced ulcers do not typically cause strictures, unlike GERD-induced ulcers 3

If Esophageal Varices Identified

  • Combination therapy with EVL plus non-selective beta-blockers (propranolol or carvedilol) to prevent rebleeding 1, 2
  • Repeat EVL every 2-8 weeks until variceal eradication 1, 2
  • Evaluate for underlying liver disease and portal hypertension 1

Prevention of Rebleeding

For Non-Variceal Causes

  • Test for H. pylori in all patients with esophageal or gastric ulcers; eradicate if positive 2, 6
  • PPI therapy for minimum 6-8 weeks, then reassess 2
  • Avoid NSAIDs, aspirin, and other ulcerogenic medications 3
  • Lifestyle modifications: elevate head of bed, avoid late meals, weight loss if overweight 1

For Variceal Bleeding

  • Combination EVL plus non-selective beta-blockers reduces rebleeding from 64% to 30% compared to medical therapy alone 1, 2
  • Periodic endoscopic surveillance to detect variceal recurrence 1

Red Flags Requiring Escalation

Indications for Rescue Therapy

  • Failure of endoscopic hemostasis despite two attempts requires angiographic embolization or surgery 1, 2
  • For variceal bleeding uncontrolled by endoscopy plus pharmacotherapy, TIPS placement is indicated 1, 2
  • Balloon tamponade can serve as bridge therapy but should not exceed 24 hours due to risk of esophageal rupture 1, 2

Complications Requiring Surgical Consultation

  • Esophageal perforation (3.4% risk with ulcers) 3, 7
  • Esophageal stricture requiring repeated dilatation (12.5% of ulcer cases) 3
  • Refractory bleeding despite optimal medical and endoscopic therapy 2

Special Considerations for Adolescents

  • Screening for Barrett's esophagus is not indicated in patients younger than 50 years regardless of GERD symptoms 1
  • Esophageal adenocarcinoma incidence is very low in younger patients, so routine cancer screening is not warranted 1
  • Consider psychosocial factors: eating disorders, intentional caustic ingestion, or medication non-compliance 3
  • Assess for risk factors: obesity, family history of GERD, smoking 1

The recurrent nature of this patient's bleeding mandates aggressive acid suppression, complete endoscopic evaluation with therapeutic intervention, and close follow-up to ensure healing and prevent life-threatening complications. 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Recurrent Hematemesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.